Market Research Blog – Page 1987 – New Product Development

Dental Flap Surgery Market is expected to reach US$ 10.31 Billion by 2032 at a compound annual growth rate of 7.5% | FMI Study

The dental landscape is seeing a significant shift towards advanced procedures for gum disease treatment. The Dental Flap Surgery Market is poised for impressive growth, reaching an estimated US$10.31 billion by 2032. This substantial increase comes from a starting point of US$5 billion in 2022, reflecting a healthy Compound Annual Growth Rate (CAGR) of 7.5% over the next decade.

The key factors driving the industry’s growth are an increase in the prevalence of periodontal disease, increased awareness about oral hygiene, and rising demand for dental flap surgery for periodontal disease treatment. Due to the high adoption rate, demand for triangular flap surgery is expected to rise during the forecast period.

Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-15760

The growing aging population and increase in dental tourism in developing countries have boosted the growth of the overall industry. An increase in the number of patients suffering from periodontal disease is anticipated to drive the industry’s growth over the years to come. Patient satisfaction wound healing and good visibility in roots are among the key factors responsible for the growth of the industry.

Key Takeaways from the Dental Flap Surgery Market Study

The triangular flap segment is expected to account for 28% market share for dental flap surgery in 2022.
Dental clinics are expected to possess a 70% market share of the dental flap surgery market in 2022.
North America is expected to possess a 40% market share of dental flap surgery in 2022.
Asia Pacific is expected to hold a 35% market share for dental flap surgery in 2022.

“The increasing awareness regarding dental health along with technological advancements in dental surgeries is boosting the growth of dental flap surgery market.” states an FMI analyst

Insights Designed for You: Customize Your Exclusive Report Today:
https://www.futuremarketinsights.com/customization-available/rep-gb-15760

Dental Flap Surgery Market Competitive Landscape

Key players in the dental flap surgery market are Aspen Dental Management, Inc., Apollo White Dental, Coast Dental, Dr. Joy Dental Clinic, Smiles by Dr. Santos, LLC, Axis Dental, Great Expressions Dental Centers, HM Hospital Madrid, Humanitas Hospital and Partha Dental Clinics. Industry participants rely on regional expansion to strengthen their market presence.

Medtronic Plc is a medical technology and services company. It is involved in manufacturing, developing, and marketing medical devices and technologies to its consumer base. The company provides its services to hospitals, clinics, distributors, other healthcare providers, and institutions. Its products are marketed across various regions, including the Asia-Pacific.
For instance, OCare has launched India’s first dental insurance plan in villages, providing quality dental care services to people across the country. Hence, there is an urgent need for the country to have an oral health policy and dental health planners who are able to understand and formulate effective oral health policies. Nevertheless, these factors mentioned above have contributed significantly to the progress of India’s periodontal market.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global dental surgery flap market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on surgery type (Triangular Flap, Rectangular Flap, Envelope Flap, Submarginal Flap, Others), by End User (Hospitals and Dental Clinics) and regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa)

Key Segments:

Dental Flap Surgery by Type:

Triangular Flap
Rectangular Flap
Envelope Flap
Submarginal Flap
Others

Dental Flap Surgery by End User:

Hospitals
Dental Clinics

Dental Flap Surgery by Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Inhalation and Nasal Spray Generic Drugs Market is expected to grow explosively at a rate of 8.96% CAGR and reach US$49 Billion by 2033 | FMI

The Inhalation and Nasal Spray Generic Drugs Market is taking a deep breath and preparing for a significant upswing. Experts predict this market to reach a staggering US$49.01 billion by 2033, fueled by a projected Compound Annual Growth Rate (CAGR) of 8.96%. This represents a substantial increase from the current market valuation of US$20.78 billion in 2023. This press release dives into the factors driving this remarkable growth trajectory for inhalation and nasal spray generic drugs.

Aging Population: A Key Driver of Market Growth

A major factor propelling this growth is the world’s rapidly aging population. As demographics shift, individuals over 60 are expected to comprise one in six people globally by 2030, according to World Health Organization projections. This number is expected to climb to a staggering 2.1 billion by 2050. This aging population is particularly susceptible to chronic respiratory conditions, leading to an increased need for inhalation and nasal spray generic drugs.

The Asthma and Allergy Foundation of America fortifies these projections, forecasting that by 2020, 7.8% of individuals over the age of 65 in the United States will be grappling with asthma. This underscores the pivotal role the industry is set to play in addressing the healthcare needs of an aging population.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15759

However, strict rules in other countries, such as Mexico and Russia, may limit demand for generic inhalation and nasal spray therapies. For example, COFEPRIS, Mexico’s regulatory authority, has adopted new criteria for generic medicine registration that may remove patents for new therapeutic uses. Furthermore, COFEPRIS has a unique generic medicine approval process in Mexico.

Key Takeaways from the Inhalation and Nasal Spray Generic Drugs Market

The Asia-Pacific area is expected to grow at a profitable CAGR of 11.23% throughout the projection period. The region’s expansion has been largely attributed to the building of strategic alliances in the region to assist the development of generic products.
North America maintained its market leadership in 2021, with a revenue share larger than 35.0%. Aside from the increasing frequency of chronic respiratory difficulties, the introduction of new products, the completion of acquisitions, and the establishment of partnerships are all important elements in the region’s growth.
Retail pharmacies had the highest revenue share in 2021, accounting for more than 55.0% of total revenue, owing to rising healthcare expenses and increased demand for generic medications.
Because of attractive reimbursement regulations and an aging population, homecare will account for more than 50.0% of total money earned in 2021.
In 2021, the adult patient segment accounted for more than 40.0% of total revenue. The key driver of the segment’s growth is a rise in the number of adult asthma and COPD patients.
Because bronchodilators are widely used to treat respiratory disorders such as asthma and COPD all over the world, the bronchodilators market segment accounted for more than 25.0% of total revenue in 2021.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15759

Inhalation and Nasal Spray Generic Drugs Market Competitive Landscape

Growth initiatives, such as product innovation, regulatory approval of new products, and mergers and acquisitions, are a primary emphasis of the Global Inhalation And Nasal Spray Generic Drugs Industry leaders. For instance, Cipla Inc. submitted an ANDA for a generic version of Advair Diskus, fluticasone propionate, and salmeterol inhalation powder in May 2020. Phase three trials of the product were successfully completed by the company in April 2020. The following companies are leaders in the global market for generic inhalers and nasal sprays:

Mylan N.V.
Akron, Operating Company LLC
Cipla Inc.
Sandoz International GmBH (Novartis AG)
Apotex Inc.
Hikma Pharmaceuticals PLC
Sun Pharmaceuticals Industries Ltd.
Beximco Pharmaceuticals Ltd

More insights available

North America is the largest inhalation and nasal spray generic market, driven by the high prevalence of respiratory diseases, a large aging population, and a well-established healthcare system. The United States is the dominant player in the region, with a significant share of the market.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/15759

Key Segments in the Inhalation and Nasal Spray Generic Drugs Market

Drug Class:

Bronchodilators
Combination Drugs
Corticosteroids
Decongestant Sprays
Antihistamines
Others

Indication:

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Allergic Rhinitis
Others

Patient Demographics:

Geriatric Patient
Adult Patient
Pediatric Patient

End-user:

Hospitals
Homecare
Others

Distribution Channel:

Hospitals Pharmacy
Retail Pharmacy
Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Handheld Dental X-rays System Market is anticipated to be valued US$ 397.1 Million By 2032, expand at a CAGR of 6.4%

The dental industry is embracing portability! The Handheld Dental X-rays System Market is expected to reach a significant US$397.1 million by 2032, reflecting a strong growth rate of 6.4% CAGR. This surge, according to a recent Future Market Insights study, is driven by the increasing popularity of systems capable of capturing over 150 X-ray shots. These versatile tools, holding a market share of approximately 58.5% in 2021, offer dentists greater mobility and convenience when capturing crucial dental images.

With age, the risk of developing diseases rises correspondingly. According to the Centres for Disease Control and Prevention (CDC), roughly one continuous ailment hurts close to 80% of senior Americans. The American Medical Association (AMA) predicts that by 2030, over 60% of persons aged 65 or older will be managing multiple chronic conditions.

The older population will spur interest in more advanced medical care facilities, and diagnostic and therapeutic options. The prevalence of age-related disorders is predicted to rise with the rapid global growth in the elderly population. Additionally, a rise in vascular, dental, and cancer illnesses is fuelling the market for handheld X-ray machines. The government is funding numerous X-ray research initiatives, which can also fuel the market’s expansion.

Government assistance may contribute to the creation of advanced products and stimulate the market during the forecast term. Such advancements are fuelling the demand for various X-ray devices such as handheld dental X-ray devices.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15762

According to the Centres for Disease Control and Prevention (CDC), periodontal disease affects around 47.2% of Americans over 30. In addition, rising dental prosthesis procedures have sparked the creation of novel dental technology, and the developed global healthcare infrastructure is actively promoting market expansion.

As a result, there are now more licences and permissions for handheld dental X-ray machines accessible on the market, which has improved the variety of goods available. To grow the industry and provide products that comply with regulations, businesses in the market are concentrating on acquiring regulatory licences.

Thus, the market for handheld dental X-ray systems will expand due to the growing usage of these products.

Key Takeaways from Handheld Dental X-rays System Market Study

The dental clinics segment dominates the handheld dental X-ray systems market with over 6% value share in 2021, owing to the increasing chronic oral diseases.
North America accounts for the highest share of 6% of the global handheld dental X-ray systems market share in 2021, due to the increased incidence of oral cancer cases, increasing elderly population and increase in the number of product approvals in this region.
>150 X-ray shots system devices accounted for the highest share of 5% of the global handheld X-rays market share in 2021, due to the new features and overall efficiency of these products.
Europe market for handheld dental X-ray systems is expected to grow at a CAGR of close to 1% over the forecast duration, owing to a rise in the awareness for oral hygiene as well as education of people regarding the treatment of periodontal diseases through these devices.

“Increasing incidence of periodontitis and associated diseases, and increasing number of approvals by the regulatory bodies to boost the market over the forecast period,” says an analyst of Future Market Insights.

Handheld Dental X-rays System Market Competition

To diversify their product offerings and increase their geographical presence, leading industry participants in the handheld dental X-ray systems market are concentrating on the development, introduction, and approval of innovative products.

On 30^th August 2021 an e-commerce portal for the selling and distribution of dental goods has reportedly been developed in India by Vatech k/as “DentGanga”. This action is a part of Vatech’s larger plan to diversify its commercial ventures in nations where it holds the largest market share.
On 20^th January 2021, PolaroidHealth launched the Rextar Portable X-Ray Generator with a pistol grip.

Handheld Dental X-rays System Market Key Companies Profiled:

KaVo Dental
VATECH
Carestream Dental LLC
Genoray
PolaroidHealth
Posdion Co., Ltd
Jiangsu Dynamic Medical Technology Co., Ltd
MaxRayDental.com
Energy Resources International Co., Ltd.
Digital Doc LLC
Dexcowin Co., Ltd
REMEDI Co., Ltd.
IATOME ELECTRIC
Dental Imaging Technologies
Changzhou Sifary Medical Technology Co. Ltd.
Denterprise Internationals
Flight Dental System
Senmy Dental

Purchase The Full Report Now!
https://www.futuremarketinsights.com/checkout/15762

Key Segments Covered in Handheld Dental X-rays System Market Research

By Product:

Upto 100 X-ray shots system
100-150 X-ray shots system
>150 X-ray shots system

By End User:

Hospitals
Dental Clinics
Group Dental Practices

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dentures Market is anticipated to expand at a 6.7% CAGR and reach an astounding US$3.2 Billion by 2032 | FMI

The Dentures Market is beaming with promise! According to a recent Future Market Insights analysis, the global market is expected to grow steadily, reaching an impressive US$3.2 billion by 2032. That’s a significant jump from its estimated value of US$1.7 billion at the end of 2022, reflecting a healthy Compound Annual Growth Rate (CAGR) of 6.7%. Interestingly, the analysis also highlights that complete dentures are expected to remain the most popular type, accounting for around 76.5% of the market share.

For people with partial and edentate dentition, Dentures are a great treatment option. Dentures are medical devices that are custom-made and recommended by dentists and dental clinical specialists to replace oral soft and hard structures. In the UK, about one in five persons wear Dentures, and the prevalence of denture use rises with age, according to an Adult Dental Health Survey. Acrylic (polymethylmethacrylate [PMMA]), metal alloys (cobalt-chromium), and polymers can all be used to make denture bases.

Request a Sample PDF of this Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-15757

Changing demographics indicate a rise in life expectancy as well as an increase in the number of elderly people. Age-related population growth has led to an increase in the number of older people who need Dentures. One of the most essential treatment choices in prosthodontics is complete Dentures.

Edentulism is a major public health issue around the world due to its high frequency (>10% in those aged 50 and up) and associated impairment. Simply put, edentulism is the absence of any natural teeth in the oral cavity. According to the World Health Organization (WHO) databanks, severe periodontal disease affects 5% to 20% of the global population. Complete edentulism is believed to occur between 7% and 69% of people worldwide.

The growing aging population needing Dentures, a changing healthcare structure, as well as growing focus on edentulism, are factors set to provide propulsion toward growth, to the overall global Dentures market, over the forecasted years.

Key Takeaways from Dentures Market Study

Acrylic for Dentures is the leading segment as material and holds approximately 4 market share in 2021. Partial and full Dentures frequently employ acrylic as their base material. Because Dentures require adjustments over time, the material’s ease of molding makes it an excellent choice for this application.
Complete denture, segmented by type, holds a market share of around 5 in 2021, as many individuals find complete Dentures to be tolerable in terms of functionality and appearance.
By usage, removable Dentures account for around 4% of the global market share in 2021, owing to the large volumes of adoption of partial removable Dentures, globally.
Dental clinics are the top end-users in the worldwide Dentures market, and this trend is anticipated to continue with a projected CAGR of 8 over the forecasted years. This is because dental clinics are the preferred location for treatment adoption in a medical environment.
North America is considered the leading region with a value share of 8 in 2021, owing to the presence of established dental care facilities in the region.

Dentures Market Competition

Through the adoption of 3D printing technology, as well as
CAD/CAM methods, key players are adopting strategies, which will cater to the customized patient demand for Dentures and dental prosthetics. Moreover, with a fragmented market space, the Dentures market comprises of several key and established players, as well as local and regional competitors.

Key developmental instances include:

A leading Silicon Valley-based digital manufacturing business, Carbon, and Dentsply Sirona announced a strategic collaboration to offer innovative denture materials for carbon digital 3D printing manufacturing solutions in January 2019.
Ivoclar Vivadent established a whole processing chain for the digital fabrication of removable Dentures in August 2020 with the Ivotion Denture System. The system’s core component is the outstanding CAD/CAM disc Ivotion, which enables the production of distinct monolithic prostheses in a single milling operation.

Key Segments Covered in Dentures Market Research

By Material:

Acrylic
Metal
Others

By Type:

Complete
Partial

By Usage:

Removable
Fixed

By End User:

Dental Clinics
Hospitals
Dental Group Practices

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Monoclonal Antibodies Market is expected to reach US$ 648.01 Billion, growing at a CAGR of 12% By 2032 | FMI

The Monoclonal Antibodies Market, a powerful weapon in the fight against disease, is experiencing explosive growth. According to a report by Future Market Insights (FMI), the global demand for this market is expected to surge at a Compound Annual Growth Rate (CAGR) of 12% during the forecast period between 2022 and 2032, reaching a staggering US$647.01 billion by 2032. This significant acceleration follows a period of steady growth, with the market registering a CAGR of 6.1% from 2017 to 2021.

Request The Sample Copy of This Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-15756

Human mAbs offer efficient modulation in effector functions and are less immunogenic as compared to chimeric or humanized mAbs. Such antibodies can be produced through the use of phage display and hybridoma technologies in transgenic mice. As a result, with recent technological progress in genetic engineering, the production of fully human mAbs is anticipated to gain traction shortly.

North America recorded the largest market share of 46.2% in 2021 due to the presence of a highly developed healthcare infrastructure, high patient awareness, and growth in cancer research prospects, among other factors. Moreover, increasing government expenditure for cancer research and the presence of key players such as Pfizer Inc., Amgen, Inc., and Merck & Co., among others, are expected to boost the market growth. Rising healthcare expenditure across the world, increasing patient awareness levels, and availability of advanced hospital infrastructure in developed countries are factors expected to result in the dominance of the segment during the forecast period.

Key Takeaways from the Monoclonal Antibodies Market Study

In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021.
The market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032
The human source type held the largest share and accounted for 54.07% of the market value in 2021.
The North American market for monoclonal antibodies expanded with a market share of 46.2% in 2022.
Asia Pacific is projected to exhibit the fastest growth rate in the forecast period.

“Applications of mAbs for the treatment of autoimmune diseases are projected to grow at a lucrative rate due to the increasing prevalence of autoimmune conditions such as rheumatoid arthritis.” comments a Future Market Insights analyst.

Request for Customization
https://www.futuremarketinsights.com/customization-available/rep-gb-15756

Monoclonal Antibodies Market Competitive Landscape

The market is expected to become more competitive shortly, as many companies focus their efforts on research and the creation of innovative diagnostic techniques through product line expansions, acquisitions, and mergers.

Key players in the Monoclonal Antibodies Market are:

Novartis AG; Pfizer Inc; GlaxoSmithKline plc; Amgen Inc.; Merck & Co., Inc.; Daiichi Sankyo Company, Limited; Abbott Laboratories; AstraZeneca plc; Eli Lilly And Company; Johnson & Johnson Services, Inc. and many more.

In November 2021, Bristol-Myers Squibb Company received the U.S. Food and Drug Administration approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) combined with limited chemotherapy as first-line treatment of metastatic or recurrent non-small cell lung cancer. Patients with squamous or non-squamous illness, independent of PD-L1 expression, are eligible for the treatment. 1 The FDA’s Real-Time Oncology Examine (RTOR) pilot programme was used to review this application, which aims to ensure that safe and effective medicines are offered to patients as soon as feasible.
In March 2022, Sanofi S.A. and Blackstone Life Sciences entered a collaboration for accelerating the development of a subcutaneous formulation of Sarclisa mAb for the treatment of patients with multiple myeloma.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global monoclonal antibodies market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on test type (tumor biomarkers tests, imaging, biopsy, liquid biopsy, immunohistochemistry, in situ hybridization), by indication (breast cancer, lung cancer, colorectal cancer, melanoma, blood cancer, prostate cancer, ovarian cancer, stomach cancer, liver cancer and others) and by end-user (hospital-associated labs, independent, diagnostic laboratories, diagnostic imaging centers, cancer research institutes and others) and regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Contact our Market Research Specialist @
https://www.futuremarketinsights.com/ask-question/rep-gb-15756

Key Segments Profiled in the Monoclonal Antibodies Market Industry Survey

Monoclonal Antibodies Market by Production Type:

In Vivo
In Vitro

Monoclonal Antibodies Market by Source Type:

Murine
Chimeric
Humanized
Human

Monoclonal Antibodies Market by End User:

Hospitals
Specialty Centers
Others

Monoclonal Antibodies Market by Application:

Oncology
Autoimmune Diseases
Infectious Diseases
Neurological Diseases
Others

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Pupillometer Market is expected to reach a valuation of US$809.56 Million by 2033, With a stable 7.7% CAGR | FMI Analysis

The world of eye exams is getting a tech upgrade! The Pupillometer Market is poised for steady growth, with a projected Compound Annual Growth Rate (CAGR) of 7.7% in the coming years. This translates to a significant market expansion, with the industry expected to reach a value of US$809.56 million by 2033, up from its current valuation of US$385.56 million in 2023. This exciting growth indicates a growing adoption of pupillometers, which are instruments used to measure pupil dilation, a key indicator for various health conditions.

Distinguished for its superior performance in comparison to digital alternatives, video pupillometers have taken center stage. These cutting-edge tools excel in efficiently capturing a comprehensive range of pupillary responses. Notably, video pupillometers leverage infrared high-definition video cameras to record bilateral pupil reactions to monocular visual stimuli.

These advancements in the pupillometer market signify a compelling growth story, as the industry moves forward into an exciting and innovative future.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-7114

Furthermore, these pupillometers are capable of capturing both spontaneous and evoked pupillary light reactions at the same time. Another prominent element contributing to increased interest in video automated pupillometer is their recent regulatory clearance. Therefore, several prominent companies in the pupillometer market are incorporating cutting-edge technologies like an LED light source, a high-precision infrared camera, and a powerful microprocessor. As a result, the market expands as a result of the increased demand brought about by these features.

Furthermore, video pupillometers are faster and more convenient in comparison with digital pupillometers. The automatic pupillometers eradicate the potential for human errors that may occur with manual approaches. As a result, this causes an increase in demand for video pupillometers, which in turn propels the development of the market. Therefore, because of these benefits, these devices are widely used in clinical practice.

Pupillometer Market Key Takeaways

The pupillometer market is spreading widely resulting in the expanding use of computers and the internet for the creation of brand-new goods. With advanced technologies combined, pupillometers consist of user-friendly controls such as binocular and monocular measures, as well as the X81705’s infinite vision distance setting, which is both fully manually adjustable. The X81705 also has an automatic off/on functionality and digital readouts that can measure down to 0.5 nm.
The demand for the automated pupillometer market is on the rise as more people seek alternatives in comparison to the traditional method of pupil measurement owing to safety concerns. According to a study published in 2016, the American Journal of Critical Care revealed that neurological nurses and critical care are constantly underestimating pupil size and incorrectly measuring pupil reactivity, leading the authors to conclude that the use of an automated pupillometer medical device is an essential tool allowing for more effective and timely diagnostics.
The significant surge in global incidences of eye problems is also fueling demand for pupillometers. The number of people with moderate or severe visual impairment is anticipated to surge to nearly 588 million by 2050 from the current estimate of 217 million, according to 2017 research by the International Council of Ophthalmology.
The demand for pupillometers is on the rise in several illnesses such as ophthalmic-related illnesses caused by prolonged use of digital electronics such as TVs, smartphones & tablets, laptops, video games, and PCs. While demand for pupillometers continues to rise, the market expansion is being stymied by a dearth of trained personnel to operate cutting-edge devices.
The growth in the global pupillometer market is anticipated over the projection period backed by a dramatic rise in the incidence of neurological diseases. Owing to technological advances, it has resulted in the surge of a new generation of pupillometers and the emergence of progressive medical devices. Pupillometers are responsible for enhancing the effectiveness of the diagnosis and helping doctors better identify brain disorders. Backed by such properties, the global pupillometer market is expected to showcase an opulent growth opportunity.

Pupillometer Market Competitive Landscape

There are numerous international and domestic players within the pupillometer industry which are making the market fiercely competitive. To maintain a competitive edge over the global pupillometer market and expand product offerings, key market players are implementing market strategies like the introduction of new, ground-breaking items as well as mergers, collaborations, and acquisitions.

More Insights into the Pupillometer Market

North America is anticipated to dominate the global pupillometer market as it accounted for over 26.3% of the global revenue. The growth of the region is attributed to the region’s largest population and high incidence of neurological and eye illnesses. Pupillometry’s widespread applicability in the United States is another factor that should boost sales.

Europe is expected to surge with a lucrative growth opportunity with an 8.8% CAGR between 2023 to 2033. Growth of the region is surging in Europe due to the rising prevalence of neurological illnesses, and the pupillometer is finding more and more uses. In addition to that, technical advancements have led to the creation of a pupillometer for the next generation, which is more advanced than the medical devices of the past.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/7114

Key Segments in the Pupillometer Market

By Mobility:

Table-top
Hand-held

By Type:

Video
Digital

By End-use:

Hospitals
Eye Clinics
Others

By Application:

Ophthalmology
Neurology
Oncology
Others

About Future Market Insights (FMI)

Contact Us:

Wheelchairs Market is predicted to reach USD 9,804.9 Million by 2034, a steady CAGR of 3.4% | FMI Study

The Wheelchairs Market is showing positive signs of progress. In 2024, the market reached a value of USD 7,018.3 million, and forecasts predict continued growth. By 2034, the wheelchair market is expected to reach a staggering USD 9,804.9 million, reflecting a steady increase at a Compound Annual Growth Rate (CAGR) of 3.4%. This significant growth indicates a rising demand for wheelchairs, likely driven by factors like increasing awareness of accessibility needs and an aging population.

In an era where innovation and accessibility intersect, FMI’s comprehensive report underscores the pivotal role of collaboration among the public, private, and nonprofit sectors. The report emphasizes that harnessing the collective skills and resources of these sectors is deemed essential to foster innovation, ultimately removing obstacles to accessibility and affordability for assistive technology (AT).

Request a Sample of this Report Using a Work Email to Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15754

A wheelchair is considered appropriate if it: satisfies the user’s demands and environmental requirements; offers a proper fit with ergonomic adjustment; is safe and reliable; is readily available in the nation; and can be obtained, maintained, and provided with services in the nation at a reasonable price. The usage of an appropriate wheelchair improves users’ mobility and flexibility, which is a requirement for active involvement in civic, professional, and educational activities.

Wheelchairs are among the most widely used assistive devices. Those who require wheelchairs have mobility limits and may include individuals with congenital abnormality, people with developmental and neurological problems (such as cerebral palsy or muscular dystrophy), people with a spinal cord injury, and people with musculoskeletal conditions (lower limb amputation), people living with physical handicap caused by polio or non-communicable diseases (NCDs) such as diabetes or stroke, and older people.

The wheelchair market is expected to grow as demand is created and consolidated around the best products in terms of effectiveness, features, quality, and cost. Additionally, to lower production costs and promote the adoption of strict quality standards, manufacturers and suppliers must collaborate to shape the Global Wheelchairs Industry for greater revenue sales.

Key Takeaways from Wheelchairs Market Study

Manual wheelchairs are the leading segment as a product, and hold approximately 5% market share in 2021, owing to their adoption by people with mobility issues, who do not suffer from chronic conditions.
The lightweight wheelchair segment is set to lead in terms of function for wheelchairs with a projected market share of around 0% by 2032, owing to the ease of its use.
Institutional sales accounted for around 2% of the Global Wheelchairs Industry, by distribution channel, in 2021, owing to the high adoption of treatment within institutional settings.
North America is considered as the leading region with a global share of 4% in 2021, owed to the large number of available distributors for wheelchairs in the region.

“Mobility issues associated with ageing are likely to affect older generations, which is predicted to raise demand for wheelchairs and fuel market expansion for wheelchairs over the forecast period,” says an analyst of Future Market Insights.

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15754

Wheelchairs Market Competition

The market for wheelchairs is highly fragmented, and there exist several competitors within the market sphere. Several local producers exist in low and middle-income nations, owing to favorable government regulations, incentives to manufacture locally, and the belief that wheelchairs are a low-tech product.

Invacare Corporation announced the release of a new, slimmer version of the Invacare® AVIVA® STORM RXTM rear-wheel drive power wheelchair in January 2022.
Sunrise Medical announced the introduction of two new electric wheelchairs in January 2022 for both its adult QUICKIE and pediatric ZIPPIE lines.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the wheelchairs market in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 – 2032. The Global Wheelchairs Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the product – (Manual Wheelchairs, and Powered Wheelchairs), function (standard transport wheel chair, self-propelled wheel chair, sports wheelchairs, standing wheelchairs, recliners wheelchairs, bariatric wheelchairs, and lightweight wheelchairs), and distribution channel (institutional sales, and retail sales), across seven key regions of the world.

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Regenerative Artificial Skin Market is projected to grow at a CAGR of 9.9%, to reach US$ 5,615.5 Million By 2032 | FMI

The global Regenerative Artificial Skin Market is expected to be valued at US$ 2,185.5 Million in 2022. This market is expanding because hospitals and clinics are increasingly in need of both temporary and permanent skin materials. The total demand for synthetic skin that is regenerative is anticipated to reach US$ 5,615.5 million in revenue by 2032, growing at a CAGR of 9.9% between 2022 and that year.

Regenerative Artificial Skin Market: Overview

The global regenerative artificial skin market is undergoing changes due to burn management reforms in several nations like the United States, the United Kingdom, and Australia. Furthermore, several companies in the marketplace increasing their product portfolio in the regenerative artificial skin market may change the market dynamics over a given period of forecast.

By material type, sub-segments such as engineered skin material in the global regenerative artificial skin market are expected to grow in positive traction owing to its immediate capability of composite skin material and success rate in artificial skin regeneration.

Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2065

According to The American Burn Association estimated that in 2015, 486,000 population received medical treatment for minor burns, and 70,000 populations were hospitalized for severe skin burns for acute care.

Skin is the biggest organ in the body also it is one of the most important organs in the body. Skin acts as a barrier between the outside environment and the inside body environment. Skin helps to maintain moisture levels in the body. Skin is responsible for the temperature regulation in the body through sweating. The skin protects the body by keeping harmful bacteria outside the body. Skin has many nerve ends, which help to respond to heat, pressure, touch, cold, and pain. Skin helps to synthesize Vitamin D, which is required for normal bone and teeth growth. The skin has a two-layer epidermal layer and a dermal layer.

The epidermal layer is the outer layer that acts as the body’s major barrier against uncertain conditions. The dermal layer is the layer of skin between the epidermal and the subcutaneous tissues. Accidental skin burns are increasing day by day. Life-threatening skin injuries, traumas, and burns require immediate surgical procedures to restore skin and avoid future complications. Skin burns may be due to heat, fire, radiation, or chemicals. Skin burns are of three levels i.e. 1st, 2nd, and 3rd degree burns. A first-degree burn affects the only outer layer of the skin causing redness, pain, and swelling, a second-degree burn affects the outer layer as well as the er skin layer and may extend downward into the dermis. Third-degree burn affects all layers of skin and deep into the internal organs.

Artificial skin is generally prepared from collagen which is easily resorbed by the body and helps to generate new skin on the affected part. Continuous research is carried out by various companies to develop new technology in artificial skin regeneration, such as autologous spray on skin by Avita Medical.

Regenerative Artificial Skin Market: Drivers and Restraints

The regenerative artificial skin market is expected to rise owing to the rising incidence of burns and increased accidents involving fire. Apart from this, increased skin diseases, harmful acid accidents, and major body surgeries positively impact the regenerative artificial skin market over the forecast period. However regulatory approval of regenerative artificial skin acts as a hamper to the growth of the market. Also acceptance by the body, sterile products, and nutritional supply to regain the natural structure hamper the growth of the regenerative artificial skin market.

Regenerative Artificial Skin Market: Region-wise Outlook

Geographically, the regenerative artificial skin market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for regenerative artificial skin market due to deeper market penetration of the procedures and the strong presence of big players in the market. Asia Pacific is anticipated to register positive growth owing to increased cosmetic surgeries and rising incidence of accidental burns.

Regenerative Artificial Skin Market: Key Players

Integra Life Sciences Corporation
Mylan N.V.
Johnson & Johnson Services, Inc.
Smith & Nephew
Mallinckrodt Plc.
Molnlycke Health Care AB
3M
Medtronic Plc.
Mimedx Group
Baxter Corporation

Purchase The Full Report Now!
https://www.futuremarketinsights.com/checkout/2065

Key Segments Covered in the Regenerative Artificial Skin Industry Analysis

Regenerative Artificial Skin Market by Material Type:

Temporary Skin Material
Single Layer Material
Bi-layered Material
Permanent Skin Material
Epidermal Skin Material
Dermal Skin Material
Composite Skin Material
Skin graft
Allograft
Xenograft
Engineered Skin Material

Regenerative Artificial Skin Market by End User:

Hospitals
Clinics
Burn Care Centers

Regenerative Artificial Skin Market by Region:

North America Regenerative Artificial Skin Market
Latin America Regenerative Artificial Skin Market
Europe Regenerative Artificial Skin Market
East Asia Regenerative Artificial Skin Market
South Asia Regenerative Artificial Skin Market
Oceania Regenerative Artificial Skin Market
Middle East & Africa Regenerative Artificial Skin Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Quadriplegia Treatment Market expected to reach US$ 2,324.4 Million by 2032 at a 4.7% CAGR | FMI Insights

The Quadriplegia Treatment Market is expected to reach US$ 2.3 billion by 2032, according to a recent analysis. This growth is driven in part by the unfortunate rise in spinal cord injuries worldwide, often caused by traffic accidents. The overall demand for quadriplegia treatments is projected to grow at a steady CAGR of 4.7% from 2022 to 2032, reflecting a significant increase from the market value of US$ 1.4 billion in 2022. This highlights the growing need for effective treatments to help those living with quadriplegia.

The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities shortly.

Key Drivers of the Quadriplegia Treatment Market

Quadriplegia is caused by spinal cord injury which is caused due to trauma at the base of the neck or skull. Some of the common causes of quadriplegia, otherwise known as tetraplegia are paralysis after any accident, tumors of the spinal cord or other spinal cord diseases. The injury to the spinal cord may cause partial or total limb paralysis.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14232

According to the 2020 data sheet of Spinal Cord Injury Statistics, it was estimated that approximately 17,810 new cases of spinal cord injuries occur every year in the U.S. Some of the reasons for quadriplegia include stroke, vehicular accidents, falls, violence, sports, medical or surgical causes and others.

According to WHO statistics, published in June 2021, 20-50 million people suffer from road traffic accidents every year which lead to non-fatal injuries yet permanent disabilities to them. With the increasing rate of road traffic accidents, the demand for quadriplegia treatment is set to show positive growth over the forecast period.

Recent technological advancements and various R&D activities in the field of quadriplegia treatment are some of the leading causes that will boost the demand for this market in forthcoming years. There is an increased level of awareness amongst patients suffering from spinal cord injuries about various treatment options available to improve their quality of life. This is another factor that will propel the demand for various treatments for quadriplegia during the forecast market.

Electrical Stimulation: Revolutionary Technique that Got Quadriplegic People Back on their Feet.

Electrical stimulators which were originally designed to treat chronic pain helped more than a dozen patients with quadriplegia to wiggle their toes, flex their legs or even walk with support.

This was a revolutionary technique that was conducted in the lab of the University of Louisville in Kentucky. Electrical stimulation thus made promising and huge gains for people with paralysis wanting to regain their functionalities. The study was published in July 2019, after which thousands of patients have enrolled in the wait lists for the electrical stimulation technique.

Quadriplegia Treatment Market: Regional Outlook

U.S. and Canada region was found to be the largest market for the diagnosis and treatment of spinal cord injury (SCI). Increasing awareness and advanced technologies are the main drivers of this market. Most of the accidents found that alcohol was one of the most important factors; that is, approximately 25% of spinal cord injuries.

In the United States, the average annual medical cost for treating an acute spinal cord injury has been found to be in the range of $ 15,000 to $ 30,000 per year. All these factors are expected to drive the market growth of the quadriplegia treatment market and offer lucrative opportunities for the providers.

Quadriplegia Treatment Market: Regional Outlook

Europe was observed to be the second-largest market, region for the quadriplegia treatment industry. Some of the factors contributing to this large market share are the presence of leading research institutes in the region for various neurological disease diagnoses and treatment. Increased awareness regarding various new technologies that help quadriplegic patients lead a relatively normal life is also another key driver for this industry in Europe.

Key player Quadriplegia Treatment Market:

Major manufacturers of medications needed to treat quadriplegia are

Merck & Co.
Sanofi Pharmaceuticals
Baxter International
Zydus Cadila
GlaxoSmithKline
AstraZeneca
Cipla
Johnson & Johnson
Bristol Myers Squibb Co.
Eli Lily & Co.
Teva Pharmaceuticals
Takeda Pharmaceutical Co Ltd
Hoffmann La Roche
Sun Pharmaceuticals.

In November 2020, Pfizer and Mylan announced the merger of Pfizer’s Upjohn generics unit and Mylan. This deal was a part of a restructuring drive at Pfizer, which was aimed at a stronger foothold in the innovative medicines division of the company.

Quadriplegia Treatment Market Key Segments:

By Treatment Type:

Corticosteroids
Non- Steroidal Anti-inflammatory Drugs (NSAIDs)
Antidepressants
- Selective serotonin reuptake inhibitors (SSRIs)
- Serotonin and norepinephrine reuptake inhibitors (SNRIs)
Anticonvulsants
Narcotic Analgesics
Antispasmodics & Muscle Relaxants
Antibiotics

By Route of Administration:

Oral
Intravenous
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores?

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-14232

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Paper and Paperboard Packaging Market Set to Reach US$ 351 Billion by 2034 | FMI

In 2024, the global paper and paperboard packaging market is poised to achieve a significant milestone, valued at US$ 223.9 billion, and is projected to expand at a steady CAGR of 4.6% to reach US$ 351 billion by 2034. This growth trajectory is propelled by escalating demand for sustainable and eco-friendly packaging solutions across diverse industries.

Core Concepts in the paper and paperboard packaging Industry

Market Value in 2024: The paper and paperboard packaging market is estimated to be valued at US$ 223.9 billion by 2024.
Projected CAGR (2024-2034): The market is expected to grow at a CAGR of 4.6% from 2024 to 2034.
Market Value in 2034: By 2034, the paper and paperboard packaging market is projected to reach US$ 351 billion.
Dominant Segment by Type: The corrugated boxes segment is anticipated to dominate the market, expanding at a 4.5% CAGR through 2034.
Leading Country: South Korea is expected to lead the market, exhibiting a strong CAGR of 6.6%.

Request Exclusive Sample Report: Paper and Paperboard Packaging Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18913

Recyclability and Environmental Friendliness:

The market’s emphasis on recyclability aligns seamlessly with consumer preferences for sustainable products. As businesses pivot towards greener alternatives, paper and paperboard packaging solutions continue to gain traction.

Growth Opportunities:

Sustainable Packaging Solutions:
- Consumers are increasingly demanding eco-friendly packaging options. Paper and paperboard offer a sustainable alternative to plastic packaging. Companies investing in biodegradable, recyclable, and compostable paper-based packaging solutions are likely to see significant growth opportunities.
Customization and Personalization:
- With advancements in printing and packaging technology, there’s a growing trend towards customized and personalized packaging. Brands can leverage digital printing techniques to create unique packaging designs that resonate with consumers. This trend opens up opportunities for companies to offer tailored packaging solutions to their clients.
E-commerce Packaging Solutions:
- The rise of e-commerce has led to a surge in demand for efficient and durable packaging solutions. Paper and paperboard packaging companies can capitalize on this trend by providing packaging solutions optimized for e-commerce logistics, such as lightweight yet sturdy packaging materials and innovative designs that enhance the unboxing experience.
Functional Packaging Innovations:
- Consumers are increasingly seeking packaging solutions that offer added functionality, such as easy opening, resealability, and enhanced product protection. Paper and paperboard packaging manufacturers can invest in research and development to create innovative packaging designs that meet these evolving consumer needs, thus gaining a competitive edge in the market.
International Market Expansion:
- With globalization on the rise, there’s an opportunity for paper and paperboard packaging companies to expand into new international markets. Emerging economies with growing consumer bases present attractive opportunities for market expansion. Companies can leverage strategic partnerships, distribution networks, and localized marketing efforts to tap into these markets and drive growth.

Request For Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-18913

Competitive Landscape

The competitive landscape of the paper and paperboard packaging market is marked by intense rivalry among key players striving for market dominance. Companies focus on innovation to meet the demand for sustainable packaging solutions across diverse industries.

Strategic collaborations, mergers, and acquisitions are common, reflecting a dynamic industry where businesses aim to strengthen their market positions and offer cutting-edge solutions in response to evolving customer needs.

Leading Players Profiled in Paper and Paperboard Packaging Industry, 2024-2034

Amcor Ltd.
ITC Ltd.
Cascades Inc.
RockTenn Company
Clearwater Paper Corporation
Packaging Corporation of America
DS Smith Plc.
Mondi Group
Metsa Group
Nippon Paper Industries Co., Ltd
Georgia-Pacific LLC

Purchase Now to Access Segment-specific Information and uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/18913

Key Segments of Paper and Paperboard Packaging Industry Survey

By Type:

Corrugated Boxes
Boxboard
Paper Bag

By Grade:

Folding Boxboard
Solid Bleached Sulfate
White Line Chipboard
Coated Unbleached Kraft Board
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: